ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2024

Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study.

Amy L McKenzie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.